このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Reckitt Benckiser Group 将来の成長

Future 基準チェック /26

Reckitt Benckiser Group利益と収益がそれぞれ年間11.3%と3.4%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に28.2% 11.8%なると予測されています。

主要情報

11.4%

収益成長率

11.7%

EPS成長率

Household Products 収益成長	8.8%
収益成長率	3.2%
将来の株主資本利益率	28.0%
アナリストカバレッジ	Good
最終更新日	14 Oct 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BMV:RB N - アナリストの将来予測と過去の財務データ ( )GBP Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	15,200	2,362	2,254	2,781	13
12/31/2025	14,651	2,137	2,084	2,535	16
12/31/2024	14,196	2,209	2,030	2,682	16
6/30/2024	14,328	1,544	2,313	2,683	N/A
3/31/2024	14,468	1,589	2,251	2,660	N/A
12/31/2023	14,607	1,634	2,188	2,636	N/A
6/30/2023	15,011	2,223	2,042	2,495	N/A
3/31/2023	14,732	2,280	2,122	2,446	N/A
12/31/2022	14,453	2,337	2,201	2,397	N/A
6/30/2022	13,524	3,037	2,997	1,822	N/A
3/31/2022	13,379	1,487	2,933	1,760	N/A
12/31/2021	13,234	-63	2,869	1,697	N/A
9/30/2021	13,457	-853	2,395	1,947	N/A
6/30/2021	13,680	-1,644	1,921	2,196	N/A
3/31/2021	13,837	-253	2,477	2,857	N/A
12/31/2020	13,993	1,137	3,032	3,518	N/A
6/30/2020	13,517	-2,737	1,946	2,354	N/A
3/31/2020	13,182	-2,761	1,457	1,883	N/A
12/31/2019	12,846	-2,785	968	1,411	N/A
6/30/2019	12,699	2,276	2,058	2,495	N/A
3/31/2019	12,648	2,220	2,073	2,510	N/A
12/31/2018	12,597	2,164	2,087	2,524	N/A
6/30/2018	12,603	3,466	1,787	2,223	N/A
3/31/2018	12,026	3,421	N/A	2,357	N/A
12/31/2017	11,449	3,376	N/A	2,491	N/A
9/30/2017	10,764	2,699	N/A	N/A	N/A
6/30/2017	10,078	2,022	N/A	2,611	N/A
3/31/2017	9,779	1,876	N/A	2,517	N/A
12/31/2016	9,480	1,729	N/A	2,422	N/A
9/30/2016	9,192	1,624	N/A	2,307	N/A
6/30/2016	8,904	1,518	N/A	2,191	N/A
3/31/2016	8,889	1,631	N/A	1,988	N/A
12/31/2015	8,874	1,743	N/A	1,784	N/A
9/30/2015	8,872	1,729	N/A	1,933	N/A
6/30/2015	8,869	1,715	N/A	2,082	N/A
3/31/2015	8,853	1,689	N/A	2,091	N/A
12/31/2014	8,836	1,663	N/A	2,099	N/A
6/30/2014	8,595	1,399	N/A	1,952	N/A
3/31/2014	8,931	1,401	N/A	2,037	N/A
12/31/2013	9,266	1,402	N/A	2,121	N/A

アナリストによる今後の成長予測

収入対貯蓄率: RB Nの予測収益成長率 (年間11.3% ) は貯蓄率 ( 7.9% ) を上回っています。

収益対市場: RB Nの収益 ( 11.3% ) MX市場 ( 11.4% ) よりも低い成長が予測されています。

高成長収益: RB Nの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: RB Nの収益 ( 3.4% ) MX市場 ( 7% ) よりも低い成長が予測されています。

高い収益成長: RB Nの収益 ( 3.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: RB Nの自己資本利益率は、3年後には高くなると予測されています ( 28.2 %)

Reckitt Benckiser Group 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Reckitt Benckiser Group plc Updates Revenue Guidance for the Full Year 2024

Reckitt Benckiser Group plc Provides Earnings Guidance for the Year 2023

Reckitt Benckiser Group plc Provides Revenue Guidance for the Full Year 2023

Reckitt Benckiser Group plc Revises Earnings Guidance for the Full Year of 2022

Recent updates

Reckitt Benckiser Reportedly Starts Talks on $7.9 Billion Homecare Assets Sale

Less than half of directors are independent

Reckitt Benckiser Group plc Updates Revenue Guidance for the Full Year 2024

Reckitt Benckiser Group plc (LSE:RKT) announces an Equity Buyback for £1,000 million worth of its shares.

Less than half of directors are independent

Reckitt Benckiser Group plc Announces Board Committee Changes

Eminence Capital Builds Stake in Reckitt Benckiser

Reckitt Benckiser Group plc Announces Demise of Olivier Bohuon, an Independent Non-Executive Director

Reckitt Benckiser Group plc Declares Final Dividend for the Year Ended 31 December 2023

Reckitt Benckiser Group plc to Report First Half, 2024 Results on Jul 24, 2024

Full year 2023 earnings released: EPS: UK£2.28 (vs UK£3.27 in FY 2022)

Investor sentiment deteriorates as stock falls 17%

Final dividend of UK£1.16 announced

Final dividend of UK£1.16 announced

Reckitt Benckiser Group plc Announces Jeffrey Carrwill to Retire from the Board on 31 March 2024

Reckitt Benckiser Group plc Recommends Final Dividend for the Year 2023, Payable on 24 May 2024

Reckitt Benckiser Group plc Announces Board Changes

Reckitt Benckiser Group plc, Annual General Meeting, May 02, 2024

Reckitt Benckiser Group plc Appoints Marybeth Hays to the Board as Non-Executive Director

New minor risk - Profit margin trend

Reckitt Benckiser Group plc Announces Board Changes

Reckitt Benckiser Group plc Announces Board Changes

Reckitt Benckiser Group plc Provides Earnings Guidance for the Year 2023

Reckitt Benckiser Group plc Announces Chief Executive Officer Changes

Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice LLC, and Spector Roseman & Kodroff P.C. Announce a $30 Million Class Action Settlement for Those Who May Have Purchased or Provided Reimbursement for the Drug Suboxone or Generic Suboxone

Reckitt Benckiser Group plc Announces Executive Changes

Reckitt Benckiser Group plc Provides Revenue Guidance for the Full Year 2023

Lysol Launches Air Sanitizer, the First Air-Care Product That Kills 99.9% of Airborne Viruses and Bacteria

Reckitt Benckiser Group plc to Report First Half, 2023 Results on Jul 23, 2023

Full year 2022 earnings released: EPS: UK£3.27 (vs UK£0.088 loss in FY 2021)

High number of new directors

Reckitt Benckiser Group plc Appoints Tamara Ingram OBE to the Board as A Non-Executive Director and Member of the Audit Committee, Effective 1 February 2023

Reckitt Benckiser Group plc Announces Directorate Change

Reckitt Benckiser Group plc to Report Fiscal Year 2022 Results on Mar 01, 2023

Reckitt Benckiser Group plc Revises Earnings Guidance for the Full Year of 2022

Independent Non-Executive Director recently bought Mex$325k worth of stock

Reckitt Benckiser Group plc Announces Chief Executive Officer Changes

Reckitt Benckiser Group plc Announces Directorate Change

First half 2022 earnings released: EPS: UK£1.88 (vs UK£2.46 loss in 1H 2021)

Reckitt Benckiser Group plc Recommends Interim 2022 Dividend, Payable on 14 September 2022

High number of new directors

Reckitt Benckiser Reportedly Weighs Shelving $7 Billion Infant Nutrition Sale

High number of new directors

Reckitt Benckiser Group plc, Annual General Meeting, May 20, 2022

Reckitt Benckiser Reportedly Looks to Complete Sale of Infant Nutrition Ops

Reckitt Benckiser Group plc Announces Sara Mathew Not Intend to Seek Re-Election as Non-Executive Director

Karo Pharma AB (publ) (OM:KARO) completed the acquisition of E45 brand and related sub-brands from Reckitt Benckiser Group plc (LSE:RKT).

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Reckitt Benckiser Group plc Recommends Final 2021 Dividend, Payable on 9 June 2022

Reckitt Benckiser Group plc to Report First Half, 2022 Results on Jul 27, 2022

Reckitt Benckiser Group plc to Report Fiscal Year 2021 Results on Feb 17, 2022

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘